avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Etv4
|
ENSMUSG00000017724.8 | ets variant 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Etv4 | mm10_v2_chr11_-_101785252_101785371 | 0.79 | 1.2e-08 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.9 | 35.7 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
3.1 | 9.3 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
2.7 | 8.2 | GO:0030221 | basophil differentiation(GO:0030221) |
2.4 | 7.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
2.3 | 9.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.0 | 8.2 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
1.8 | 8.9 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.7 | 6.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.7 | 5.0 | GO:2001189 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
1.4 | 5.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.3 | 8.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.3 | 10.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.3 | 3.8 | GO:0015866 | ADP transport(GO:0015866) |
1.1 | 8.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.1 | 7.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.1 | 3.2 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) negative regulation of extracellular matrix disassembly(GO:0010716) |
1.1 | 6.3 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
1.0 | 10.4 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.0 | 3.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.0 | 2.9 | GO:0051659 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
0.9 | 5.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.9 | 11.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.9 | 3.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.9 | 2.7 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.9 | 6.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.9 | 0.9 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.9 | 4.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.9 | 7.8 | GO:0036371 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.9 | 3.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.9 | 11.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.8 | 4.0 | GO:0071104 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
0.8 | 7.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.8 | 3.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.8 | 5.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.8 | 2.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 | 3.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 2.9 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.7 | 2.2 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.7 | 2.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 3.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 4.8 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.7 | 3.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.7 | 4.6 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.7 | 8.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 5.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 3.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.6 | 4.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.5 | 1.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 1.6 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.5 | 9.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 2.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.5 | 1.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 1.0 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.5 | 2.0 | GO:0010286 | heat acclimation(GO:0010286) |
0.5 | 2.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 0.5 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.5 | 3.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 1.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.5 | 1.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 5.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.4 | 1.3 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.4 | 1.3 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.4 | 1.2 | GO:0043519 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) regulation of bleb assembly(GO:1904170) |
0.4 | 0.8 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.4 | 0.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.4 | 2.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 1.6 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.4 | 1.2 | GO:1901355 | response to rapamycin(GO:1901355) |
0.4 | 1.9 | GO:0044849 | estrous cycle(GO:0044849) |
0.4 | 5.4 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.4 | 1.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.4 | 1.1 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
0.4 | 8.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 1.1 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.4 | 7.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 1.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 7.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 7.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 1.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 4.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 4.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 2.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 4.6 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 0.9 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.3 | 1.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 1.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 4.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 3.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 3.8 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 0.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 1.4 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.3 | 3.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 2.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 2.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.1 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.3 | 2.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 0.8 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 1.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 1.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 1.1 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.3 | 2.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.5 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.3 | 2.0 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.2 | 6.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 8.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 1.9 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.0 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 3.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.4 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 2.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.9 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 3.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 3.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 3.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.1 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 1.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 1.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 2.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.6 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.2 | 7.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 3.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 1.0 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.2 | 7.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 2.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 3.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.2 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.2 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 0.5 | GO:2000556 | T-helper 1 cell cytokine production(GO:0035744) regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.2 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 1.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 19.2 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 1.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 3.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 2.4 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 2.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 1.0 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 3.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) leading strand elongation(GO:0006272) |
0.2 | 0.8 | GO:0090290 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.2 | 1.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 2.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.5 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 1.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.3 | GO:0001805 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.1 | 1.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 2.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.4 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.4 | GO:0046549 | phenol-containing compound catabolic process(GO:0019336) retinal cone cell development(GO:0046549) |
0.1 | 2.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 1.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 8.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 1.5 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 3.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.7 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.8 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.1 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 1.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 1.1 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 1.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 1.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 2.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 1.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 1.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 1.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 2.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 2.0 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.3 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.1 | 3.8 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.7 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 0.5 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 4.0 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.8 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 2.7 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 3.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 3.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 1.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 3.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 1.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 1.0 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 2.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 1.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 2.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.8 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 2.6 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.7 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 2.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 1.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 2.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 1.4 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.1 | 0.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 3.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 2.7 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 1.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 1.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 1.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 1.9 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.6 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:2000584 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.0 | 0.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 2.8 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 1.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 3.9 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 1.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 1.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.4 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.0 | 0.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.5 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.4 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.0 | 1.2 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:2000078 | columnar/cuboidal epithelial cell maturation(GO:0002069) positive regulation of type B pancreatic cell development(GO:2000078) |
0.0 | 0.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 33.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.6 | 6.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.5 | 10.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.3 | 7.8 | GO:0097443 | sorting endosome(GO:0097443) |
1.3 | 6.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.1 | 6.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.0 | 6.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.9 | 2.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.9 | 2.7 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.7 | 9.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 2.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 8.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.7 | 8.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 5.7 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 7.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 10.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 9.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 4.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 3.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 1.5 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.5 | 5.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 3.0 | GO:0031673 | H zone(GO:0031673) |
0.5 | 2.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 2.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.5 | 3.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 2.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 1.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.4 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 3.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 3.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 0.9 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.3 | 7.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 0.9 | GO:0036019 | endolysosome(GO:0036019) |
0.3 | 2.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 6.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 1.3 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 11.1 | GO:0031430 | M band(GO:0031430) |
0.2 | 3.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 9.3 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 13.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 4.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 9.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 2.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 1.9 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 14.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 2.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 8.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 2.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 1.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 3.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 6.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 2.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 2.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 2.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 7.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 1.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 3.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 7.1 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 1.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 13.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.5 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 7.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 2.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 3.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 3.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 7.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 2.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.2 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.1 | 4.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 1.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 1.4 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 2.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 5.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 13.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 2.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 1.3 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 2.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 7.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.5 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.0 | GO:0019034 | viral replication complex(GO:0019034) |
0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 2.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 1.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 3.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 2.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.2 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
2.7 | 8.0 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
2.6 | 7.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
2.6 | 10.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.8 | 7.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.7 | 8.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.4 | 5.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.3 | 6.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.0 | 9.4 | GO:0033691 | sialic acid binding(GO:0033691) |
1.0 | 9.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 2.9 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
1.0 | 4.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.9 | 5.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 6.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 9.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.8 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.7 | 2.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.7 | 15.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 5.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 1.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.6 | 2.5 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.6 | 1.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 2.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.6 | 6.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.6 | 35.5 | GO:0004601 | peroxidase activity(GO:0004601) |
0.5 | 8.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 4.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 8.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 1.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 1.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.3 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.4 | 1.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.4 | 1.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.4 | 1.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) prostaglandin-E synthase activity(GO:0050220) |
0.4 | 1.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 2.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 2.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 4.7 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 2.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 2.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 2.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 3.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.3 | 7.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 10.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 0.9 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.3 | 3.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 4.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 4.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.3 | 5.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.7 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 2.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 2.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 1.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 1.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 2.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.4 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.2 | 3.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 7.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 2.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 3.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 10.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 5.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 3.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 2.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 4.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 7.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 3.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 5.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 2.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 7.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 3.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 2.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 6.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.1 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 2.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.1 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 9.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 4.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 3.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 3.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.9 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 2.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 2.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 4.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 1.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 3.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 6.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 1.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 2.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 6.5 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 13.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 1.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.1 | 3.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 2.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 7.1 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 2.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 8.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 1.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 2.8 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 3.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 11.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 1.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 1.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 1.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 4.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 7.4 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 19.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 42.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 7.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 15.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 6.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 2.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 7.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 15.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 11.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 9.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 8.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 10.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 5.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 3.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 7.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 6.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 10.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 6.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 8.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 4.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 4.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 10.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 7.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 11.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 2.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 2.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 6.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 15.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 6.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 8.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 6.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 5.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 5.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 4.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 5.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 2.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 4.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 9.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 13.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 25.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 9.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 6.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 3.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 2.9 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 7.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 5.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 3.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 3.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 2.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 2.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 13.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 4.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 11.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 3.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 4.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 5.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 7.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 4.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 3.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 7.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 2.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 2.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 4.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 2.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 2.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |